Leading FCA-regulated fintech fund manager, SyndicateRoom, has announced the launch of its first university-partnered Enterprise Investment Scheme (EIS) Fund in collaboration with the University of Nottingham, opening new opportunities for investors to access one of the United Kingdom’s most promising deep-tech and life sciences innovation ecosystems.
The new fund represents a significant milestone for SyndicateRoom as it combines the company’s data-driven investment expertise with the University of Nottingham’s world-renowned research and innovation pipeline. The partnership was officially unveiled during the university’s recent Spin-Out Summer Celebration.
According to SyndicateRoom, the initiative is designed to bridge the gap between groundbreaking academic research and commercial investment by providing structured funding support to high-potential university spin-out companies.
With over a decade of experience in early-stage venture investing, SyndicateRoom has built a reputation for deploying capital into hundreds of high-growth startups. Through its investment platform and analytical approach, the company will manage the fund and provide investors with access to carefully selected startups emerging from the University of Nottingham.
The fund is expected to focus primarily on deep technology, life sciences, sustainability, advanced engineering, and healthcare innovations.
Speaking on the partnership, SyndicateRoom Co-founder, Tom Britton, described the collaboration as a natural extension of the firm’s investment philosophy.
“The University of Nottingham has a phenomenal track record of translating world-class research into commercially viable, high-impact companies. This EIS Fund provides our investors with a highly curated opportunity to support pioneering businesses at an early stage while contributing to broader economic growth and innovation,” Britton said.
The University of Nottingham is ranked among the UK’s leading research institutions and has established itself as a major hub for life sciences and deep-tech spin-outs. Its commercialisation arm, Nottingham Technology Ventures (NTV), has developed a portfolio of more than 40 active spin-out companies over the past decade.
Professor Jane Norman, President and Vice-Chancellor of the University of Nottingham, highlighted the importance of investor confidence in transforming research into impactful businesses.
“Without the support, backing and belief of investors, many of these ventures would never have the opportunity to grow and realise their full potential,” she said.
Also commenting, Glen Crocker, Executive Director at The Pioneer Group, described the new fund as an important development for the university’s innovation ecosystem.
“This initiative strengthens the bridge between academic excellence and investment while creating a pathway for world-class research to deliver real-world impact at scale,” Crocker noted.
The University of Nottingham’s portfolio includes several high-performing spin-out companies already making significant progress across various sectors.
One of them, Vet Vision AI, uses artificial intelligence to improve animal health and welfare through continuous monitoring systems designed by veterinary experts.
Another, Forge Genetics, operates at the forefront of synthetic biology, developing advanced gene-editing technologies that offer alternatives to existing market-leading systems.
Meanwhile, Neurotherapeutics, trading as Neupulse, is developing wearable medical technology aimed at improving the lives of people living with neurological conditions such as Tourette Syndrome, Parkinson’s Disease, anxiety disorders, and obsessive-compulsive disorder.
Through the newly launched fund, investors will gain exposure to a diverse range of sectors including clean technology, artificial intelligence, healthcare innovation, advanced engineering, and sustainability-focused enterprises.
Industry observers view the partnership as part of a growing trend in the UK innovation sector, where universities and investment firms are working together to accelerate the commercialisation of research and create new opportunities for economic growth.
The launch underscores the increasing importance of university spin-outs in driving technological advancement and attracting private investment into research-led businesses.
Disclaimer: Investments in early-stage companies carry significant risks, including the potential loss of capital. Prospective investors are advised to seek independent financial advice before making investment decisions.
